DOCS Stock: Price, Earnings History and SEC Filings
Doximity, Inc. (DOCS) last traded at $32.76, down 2.59% on the latest session and up 15.6% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $0.14 against an analyst estimate of $0.16, a miss of 12.5%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
DOCS earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $0.14 | $0.16 | -12.50% |
| Mar 2026 | May 13, 2026 | $0.11 | $0.17 | -35.29% |
| Dec 2025 | Feb 5, 2026 | $0.33 | $0.32 | +3.13% |
| Sep 2025 | Nov 6, 2025 | $0.33 | $0.28 | +17.86% |
DOCS beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
How DOCS reacts to earnings
Across its last 8 earnings releases, DOCS moved 22.4% on average the next session, in either direction. It rose after 4 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-06 | After close | +32.62% |
| 2026-05-13 | After close | -23.00% |
| 2026-02-05 | After close | -16.78% |
| 2025-11-06 | After close | -13.25% |
| 2025-08-07 | After close | +13.71% |
| 2025-05-15 | After close | -10.08% |
| 2025-02-06 | After close | +35.99% |
| 2024-11-07 | After close | +34.15% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
DOCS financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | $645M | $196M | $326M | 30.4% | $0.98 |
| 2025 | $570M | $223M | $273M | 39.1% | $1.11 |
| 2024 | $475M | $148M | $184M | 31.0% | $0.72 |
| 2023 | $419M | $113M | $178M | 26.9% | $0.53 |
| 2022 | $344M | $155M | $125M | 45.1% | $0.70 |
| 2021 | $207M | $50M | $83M | 24.3% | $0.23 |
| 2020 | $116M | $30M | $26M | 25.5% | $0.13 |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for DOCS
- 8-K · Sep 2, 2026Shareholder vote
- 10-Q · Aug 6, 2026
- 8-K · Aug 6, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Jul 15, 2026
- 10-K · May 19, 2026
- 8-K · May 13, 2026Results of operations, Officer or director change, Financial statements and exhibits
- 8-K · Apr 17, 2026Officer or director change, Regulation FD disclosure
- 10-Q · Feb 5, 2026
- 8-K · Feb 5, 2026Results of operations, Officer or director change, Financial statements and exhibits
- 8-K · Dec 30, 2025Other events
Insider filing activity
DOCS insiders filed 17 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
DOCS news
- TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now?Oct 30, 2026 · finance.yahoo.com
- Doximity (DOCS) Registers a Bigger Fall Than the Market: Important Facts to NoteOct 29, 2026 · finance.yahoo.com
- Doximity Launches DoseCheck to Catch Dangerous AI Drug Dosing Errors Before They Reach DoctorsOct 29, 2026 · finance.yahoo.com
- Can Wolters Kluwer (ENXTAM:WKL) Keep Looking Cheap On Earnings?Oct 29, 2026 · finance.yahoo.com
- Doximity (DOCS) Stock Gets Fair Value Bump As Analysts Split On AI And MarginsOct 22, 2026 · finance.yahoo.com
- Stocks making big moves yesterday: Washington Trust Bancorp, Doximity, Myriad Genetics, Arhaus, and GartnerOct 21, 2026 · finance.yahoo.com
- Why Is Doximity (DOCS) Stock Rocketing Higher TodayOct 20, 2026 · finance.yahoo.com
- OpenEvidence, Doximity settle thorny AI legal battleOct 20, 2026 · healthcaredive.com
About Doximity, Inc.
Doximity, Inc. (DOCS) is a US-listed public company on NYSE. The SEC classifies its business as Services-computer Programming Services. It is incorporated in DE. Its fiscal year ends in March.